Publication

Article

Pharmaceutical Executive

Pharmaceutical Executive-01-01-2022
Volume42
Issue 1

Pharmaceutical Executive, January 2022 Issue (PDF)

Click cover to access digital PDF

Download Issue PDF
Articles in this issue
Keeping Tabs on Quality: The Rise of Digital
Keeping Tabs on Quality: The Rise of Digital
China Invests in Building Biotech
Branding Takes on a New Look
Addressing Access Burdens
Meeting the Patient—Virtually
The Age of Influence

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Gen Li
Pharmaceutical Executive
Pharmaceutical Executive
Related Content
Stock.adobe.com
October 3rd 2025

Takeda Announces Decision to Discontinue Cell Therapy Research

Nicholas Jacobus
Pharmaceutical Executive
October 3rd 2025

Pharmaceutical Executive Daily: President Trump Pauses Tariff Plan

Nicholas Jacobus
Stock.adobe.com
October 3rd 2025

FDA Announces Ramifications of Government Shutdown Due to 2026 Lapse in Funding

Nicholas Jacobus
Pharmaceutical Executive
October 3rd 2025

Pharmaceutical Executive Daily: Novo Nordisk Resubmits BLA for Awiqli

Nicholas Jacobus
AI and R&D: From the Eyes of an Entrepreneur
October 3rd 2025

AI and R&D: From the Eyes of an Entrepreneur

Michael Christel
How Cell and Gene Therapy Developers Can Reduce Risk of FDA Complete Response Letters With Proactive CMC Strategies
October 3rd 2025

How Cell and Gene Therapy Developers Can Reduce Risk of FDA Complete Response Letters With Proactive CMC Strategies

Louis Cicchini, PhD, and Michael Day, PhD
© 2025 MJH Life Sciences

All rights reserved.